Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in Vivo
Open Access
- 1 July 2008
- journal article
- retraction
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (29), 20186-20197
- https://doi.org/10.1074/jbc.m803020200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-ζ Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial CellsCirculation, 2008
- AMP‐ACTIVATED PROTEIN KINASE ACTIVATION AS A STRATEGY FOR PROTECTING VASCULAR ENDOTHELIAL FUNCTIONClinical and Experimental Pharmacology and Physiology, 2007
- Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitusAtherosclerosis, 2007
- Peroxynitrite and protein tyrosine nitration of prostacyclin synthaseProstaglandins & Other Lipid Mediators, 2007
- Metformin Inhibits Cytokine-Induced Nuclear Factor κB Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial CellsHypertension, 2006
- Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinaseCell Metabolism, 2005
- AMP-activated protein kinase, super metabolic regulatorBiochemical Society Transactions, 2003
- Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative StressHypertension, 2002
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Neuroprotection mediated by changes in the endothelial actin cytoskeletonJournal of Clinical Investigation, 2000